The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design

Abstract

Global ETNA will generate the largest integrated prospective repository of routine clinical care data for a single NOAC in patients with AF or VTE. It will provide important information on the safety of edoxaban in routine clinical care and gather further information on its effectiveness.